| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | VREX | Common Stock | Options Exercise | $264K | +8.6K | +11.68% | $30.74 | 82.2K | Dec 23, 2021 | Direct | F1 |
| transaction | VREX | Common Stock | Sale | -$275K | -8.6K | -10.46% | $32.00 | 73.6K | Dec 23, 2021 | Direct | F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | VREX | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -8.6K | -12.2% | $0.00 | 61.9K | Dec 23, 2021 | Common Stock | 8.6K | $30.74 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | Amount of securities beneficially owned at end of reporting period reflect 2,945 shares purchased under the Varex Imaging Corporation 2017 Employee Stock Purchase Plan. |
| F2 | The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on March 16, 2021. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.00 to $32.03. The reporting person undertakes to provide Varex Imaging Corporation, any security holder of Varex Imaging Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. |
| F3 | The non-qualified stock options were subject to a three-year vesting period. One-third vested on February 13, 2016, and the remaining two-thirds vested on a pro-rata basis monthly thereafter. |